Login to Your Account

Clinic Roundup

Friday, March 22, 2013
• Bioheart Inc., of Sunrise, Fla., said it secured sufficient funding to begin the Phase I ANGEL safety and efficacy trial of LipiCell (adipose-derived stem cells) in congestive heart failure.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription